Xenon Pharmaceuticals (XENE) EBT Margin (2013 - 2025)
Xenon Pharmaceuticals (XENE) reported EBT Margin of 861.6% for Q1 2025, up 96.99% quarter-over-quarter from 28588.64% in Q3 2022.
Xenon Pharmaceuticals (XENE) EBT Margin (2013 - 2025) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 10 years of EBT Margin data on file, last reported at 861.6% in Q1 2025.
- EBT Margin for Q1 2025 came in at 861.6%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 82.28% (changed N/A YoY), and the FY2025 annual result was 82.28%, changed N/A from the prior year.
- EBT Margin improved to 861.6% in Q1 2025 per XENE's latest filing, from 28588.64% in the prior quarter.
- Over five years, EBT Margin peaked at 228.88% in Q1 2022 and troughed at 28588.64% in Q3 2022.
- A 3-year average of 4736.05% and a median of 766.36% in 2021 frame the typical range for EBT Margin.
- On a YoY basis, EBT Margin climbed as much as 13440 bps in 2022 and fell as far as 2824086 bps in 2022.
- A 3-year view of EBT Margin shows it stood at 671.13% in 2021, then sank by 4160 bps to 28588.64% in 2022, then jumped by 97 bps to 861.6% in 2025.
- Business Quant data shows XENE's EBT Margin at 861.6% in Q1 2025, 28588.64% in Q3 2022, and 5820.52% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -861.60% |
| Sep 30, 2022 | -28,588.64% |
| Jun 30, 2022 | -5,820.52% |
| Mar 31, 2022 | -228.88% |
| Dec 31, 2021 | -671.13% |
| Sep 30, 2021 | -347.78% |
| Jun 30, 2021 | -1,006.58% |
| Mar 31, 2021 | -363.29% |
| Dec 31, 2020 | -239.55% |
| Sep 30, 2020 | -138.21% |
| Jun 30, 2020 | -1.60% |
| Mar 31, 2020 | -105.75% |
| Dec 31, 2019 | -342.81% |
| Sep 30, 2019 | -253.31% |
| Dec 31, 2017 | -49,725.00% |
| Sep 30, 2017 | -3,227.27% |
| Jun 30, 2017 | -51,893.33% |
| Mar 31, 2017 | -48,987.50% |
| Dec 31, 2016 | -1,407.98% |
| Sep 30, 2016 | -1,747.46% |